These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16540256)

  • 1. WBC and inflammatory status: potential susceptibility biomarkers for obesity, diabetes, cancer and aging?
    Lim CS
    Med Hypotheses; 2006; 67(3):678. PubMed ID: 16540256
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin, the hypovolaemia hormone, aggravates hypertension, obesity, diabetes and cancer.
    Thornton SN
    J Intern Med; 2009 May; 265(5):616-7. PubMed ID: 19019186
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammation: another potential mechanism between diabetes mellitus and atrial fibrillation.
    Liu T; Li G
    Am J Cardiol; 2008 Jun; 101(11):1681-2. PubMed ID: 18489956
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between adiponectin, inflammatory markers and obesity in type 2 diabetic and non-diabetic Trinidadians.
    Nayak S; Soon SQ; Kunjal R; Ramadoo R; Baptiste O; Persad J; Temull V; Diptee L; Balgobin S
    Arch Physiol Biochem; 2009 Feb; 115(1):28-33. PubMed ID: 19267280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study.
    de Rekeneire N; Peila R; Ding J; Colbert LH; Visser M; Shorr RI; Kritchevsky SB; Kuller LH; Strotmeyer ES; Schwartz AV; Vellas B; Harris TB
    Diabetes Care; 2006 Aug; 29(8):1902-8. PubMed ID: 16873800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
    Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
    Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance.
    Lewis JG; Shand BI; Elder PA; Scott RS
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e13-5. PubMed ID: 18194820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, inflammation, and insulin resistance.
    Shoelson SE; Herrero L; Naaz A
    Gastroenterology; 2007 May; 132(6):2169-80. PubMed ID: 17498510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents.
    Syrenicz A; Garanty-Bogacka B; Syrenicz M; Gebala A; Walczak M
    Neuro Endocrinol Lett; 2006 Aug; 27(4):453-8. PubMed ID: 16892000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.
    Calabro P; Yeh ET
    Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric obesity: an inflammatory condition?
    Sacheck J
    JPEN J Parenter Enteral Nutr; 2008; 32(6):633-7. PubMed ID: 18974243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal obesity and markers of inflammation in pregnancy.
    Madan JC; Davis JM; Craig WY; Collins M; Allan W; Quinn R; Dammann O
    Cytokine; 2009 Jul; 47(1):61-4. PubMed ID: 19505831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA
    Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions.
    Rüegg C
    J Leukoc Biol; 2006 Oct; 80(4):682-4. PubMed ID: 16849612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipolysis and lipogenesis in obesity and in diabetes mellitus (plasmatic response)].
    Yáñez Polo MA
    Rev Clin Esp; 1971 Nov; 123(4):326-34. PubMed ID: 5157914
    [No Abstract]   [Full Text] [Related]  

  • 18. Components of metabolic syndrome predicting diabetes: no role of inflammation or dyslipidemia.
    Norberg M; Stenlund H; Lindahl B; Andersson C; Weinehall L; Hallmans G; Eriksson JW
    Obesity (Silver Spring); 2007 Jul; 15(7):1875-85. PubMed ID: 17636107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTM1 and TNF-alpha gene polymorphisms and relations between blood lead and inflammatory markers in a non-occupational population.
    Kim JH; Lee KH; Yoo DH; Kang D; Cho SH; Hong YC
    Mutat Res; 2007 Apr; 629(1):32-9. PubMed ID: 17298885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus.
    Gomes MB; Cobas RA; Nunes E; Castro-Faria-Neto HC; da Matta MF; Neves R; Tibiriçá E
    Diabetes Res Clin Pract; 2009 Jul; 85(1):61-8. PubMed ID: 19464746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.